Loading patent…
AssigneesCentre National de la Recherche Scientifique (CNRS), Universite De Nice Sophia Antipolis
InventorsJean Mazella, Olivier Petrault, Marc Borsotto, Catherine Heurteaux, Catherine Widmann
Estimating the term…
The invention relates to a peptide derived from neurotensin receptor 3 (NTSR3), and to the use thereof in the treatment of psychiatric diseases. The present invention particularly relates to the use of this peptide for producing a drug, such as an antidepressant. The peptide of the invention is characterized in that the sequence thereof is the attached SEQ ID No. 2. The present invention can be used in the fields of the pharmaceutical industry and particularly in the field of drug development for treating psychiatric diseases. The present invention can also be used in the development of a novel antidepressant. It can also be used for example, in the treatment of pain and inflammations.
A peptide of sequence ID No. 2 or a fragment or a derivative of said peptide which is a ligand of the neurotensin receptor 3 (NTSR3).
A method of production of a peptide of Sequence ID No. 2 or fragment or derivative thereof which is a ligand of the neurotensin 3 (NTSR3) comprising the following stages:
Method for the manufacture of a medicinal product intended for the treatment of psychiatric disorders, and of inflammatory and/or painful phenomena comprising administering a peptide of Sequence ID No 2.
A method of production of a peptide of Sequence ID No. 2 or fragment or derivative thereof which is a ligand of the neurotensin receptor 3 (NTSR3) comprising the following stages:
Dependencies are inferred from the claim text.